Structure Therapeutics
Jun Y. has a diverse and extensive work experience in the biotechnology and life sciences industry. Jun started their career as a researcher at The Scripps Research Institute in 1999. Jun later moved on to roles in business development at Syrrx, MemRx Corporation, Sagres Discovery, and VIA Pharmaceuticals. At VIA Pharmaceuticals, they served as the Sr. Director of Licensing & Business Development. Jun then joined Cellerant Therapeutics as the Vice President of Corporate Development in 2010. In 2014, Jun Y. became a Board Member at The GPCR Consortium. Jun also worked as an independent consultant in the biotechnology and life sciences industry. Jun joined Structure Therapeutics in 2016 as the Chief Financial Officer.
Jun Y. holds a Bachelor's Degree in Molecular Cell Biology from the University of California, Berkeley. The duration of their education at this institution is unspecified.
This person is not in the org chart
This person is not in any offices
Structure Therapeutics
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations inbiologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.